NDC 0143-9658-01 - Acyclovir
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0143-9658
- Requested NDC
- 0143-9658-01
- Package NDCs from labels
- 0143-9658-01, 0143-9658-10
- Manufacturer
- Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A
- Effective date
- 2024-04-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Acyclovir - Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | 2024-04-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0143-9658-01 | Acyclovir | 1 in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 1 | 5 | |
| 0143-9658-10 | Acyclovir | 10 in 1 BOX | INJECTION, POWDER, LYOPHILIZED, | 10 | 5 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acyclovir Sodium | ACYCLOVIR SODIUM | ProPharma Distribution | 23a7cf9e-f21b-06c2-e063-6394a90aa623 | 2025-07-18 | Warnings, Adverse reactions | 927L42J563 |
| acyclovir | ACYCLOVIR | Fresenius Kabi USA, LLC | b1bb347d-74f4-4976-8450-a375a271718f | 2024-11-13 | Warnings, Adverse reactions | 927L42J563 |
| Acyclovir | ACYCLOVIR | Fresenius Kabi USA, LLC | badf347b-eeee-4239-9c74-966f262925aa | 2024-06-30 | Warnings, Adverse reactions | 927L42J563 |
| Acyclovir | ACYCLOVIR | Fresenius Kabi USA, LLC | cb64dfab-52ee-4312-bc9c-c3d04efe9109 | 2024-06-27 | Warnings, Adverse reactions | 927L42J563 |
| Acyclovir | ACYCLOVIR | Hikma Pharmaceuticals USA Inc. | babdbce2-5cbd-4943-bc38-9ebdd696a77a | 2024-04-11 | Warnings, Adverse reactions | ANDA205771 0143-9658-10 0143-9657-01 0143-9658-01 0143-9657-10 0143-9658 0143-9657 00143965801 2263505 2263503 dbf69540-34d6-423d-a06a-e5eddfd40ae3 babdbce2-5cbd-4943-bc38-9ebdd696a77a 927L42J563 |
| acyclovir | ACYCLOVIR | Slate Run Pharmaceuticals, LLC | 889bccd1-3793-40ce-bca2-c8c9cf6b7488 | 2024-02-29 | Warnings, Adverse reactions | 927L42J563 |
| Acyclovir Sodium | ACYCLOVIR SODIUM | Eugia US LLC | ae921e4e-b8ae-4a45-acc1-32e5e719812b | 2023-07-05 | Warnings, Adverse reactions | 927L42J563 |
| acyclovir | ACYCLOVIR | Zydus Lifesciences Limited | 383b930b-6e9c-4ac9-a078-baac6276f340 | 2022-10-17 | 927L42J563 | |
| acyclovir | ACYCLOVIR | Zydus Pharmaceuticals (USA) Inc. | 69a98000-adef-4323-89a7-09e035a257d4 | 2021-11-29 | Warnings, Adverse reactions | 927L42J563 |
| Acyclovir Sodium | ACYCLOVIR SODIUM | AuroMedics Pharma LLC | d3ab226c-677d-4cb7-85cb-1c2e5012f40d | 2017-09-18 | Warnings, Adverse reactions | 927L42J563 |